CCCC · Company research
C4 Therapeutics, Inc. (CCCC): Valuation Analysis
Available valuation snapshots and ratios; unavailable metrics remain blank.
RESEARCH CONTEXT
Understand the numbers
Available valuation snapshots and ratios; unavailable metrics remain blank. Use period, currency, units and source fields when interpreting values.
1records availableHealthcare
Valuation Analysis data
Database-backed records only
| valuation date | price | market cap | enterprise value | pe | forward pe | peg | price sales | price book | price fcf |
|---|---|---|---|---|---|---|---|---|---|
| Oct 8, 2026 | 2.82 | $392,722,238.83 | 331448238.825 | — | — | — | 63.8365147634915475 | 1.6765304948409158 | — |
Informational research only, not financial advice. Forecasts are uncertain and can be wrong.
